The national drugs strategy covers the period up to 2008. Its mid-term evaluation will, I hope, inform us on how to build further upon the firm foundations put in place. While much progress has already been made, we need to continue our efforts to drive the strategy forward. In this regard, I look forward to hearing Senators' contributions.